Synonym: N-(3-Butenyl)norbuprenorphine; (αS,5α,7α)-17-(3-Buten-1-yl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6,14-ethenomorphinan-7-methanol
CAS Number: 457071-73-7
Empirical Formula (Hill Notation): C29H41NO4
Molecular Weight: 467.64
Linear Formula: C29H41NO4
Product Type: Chemical
| API family |
buprenorphine |
| application(s) |
pharmaceutical (small molecule) |
| drug control |
USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal) |
| format |
neat |
| grade |
pharmaceutical primary standard |
| manufacturer/tradename |
USP |
| Analysis Note: |
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: |
Buprenorphine Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
| General description: |
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: |
Sales restrictions may apply. |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
